MedPath

Vitamin D Substitution During Winter Time

Phase 4
Conditions
Vitamin D Substitution
Interventions
Registration Number
NCT02958501
Lead Sponsor
Faculty Hospital Kralovske Vinohrady
Brief Summary

The purpose of this study is to confirm anticipated substitution dose of the vitamin D for sustained blood level during winter time in patients with inflammatory bowel diseases (IBD)

Detailed Description

Vitamin D substitution is widely recommended. Suggested substitution doses are increasing over the time. No exact body requirement is known for patients with IBD at present. Aim of the study was to confirm substitution dose obtained from model.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
176
Inclusion Criteria
  • Subjects with inflammatory bowel disease
Exclusion Criteria
  • Liver disease
  • Renal disease
  • Hypercalcemia
  • Hyperparathyreoidism
  • Chronic pancreatitis
  • Concomitant vitamin D medication
  • Pregnancy
  • Sarcoidosis
  • Malignancy
  • Inability to obtain valid data from subject

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IU/Kg/DayColecalciferolThis is dose of the drug (colecalciferol), which is based or calculated in relation to patient actual body weight
IU/DayColecalciferolThis is standard dose of the drug (colecalciferol), which is not calculated in relation to patient body weight
Primary Outcome Measures
NameTimeMethod
Change in vitamin D blood level after follow-up interval4 Months

Change of the D vitamin level after follow-up interval in groups substituted according to weight or in fixed daily dose.

Secondary Outcome Measures
NameTimeMethod
Change in vitamin D after follow-up interval according to weight4 Months

Change in vitamin D after follow-up interval according to weight. Superiority of weight base dosing to fixed daily dose.

Trial Locations

Locations (1)

Faculty Hospital Kralovske Vinohrady

🇨🇿

Prague, Czech Republic

© Copyright 2025. All Rights Reserved by MedPath